Relationship Between Fasting Blood Glucose and Readmission Within 1 Year in Elderly Patients with Heart Failure

 

 Buy Article Permissions and Reprints

Abstract

Introduction Elevated blood glucose has been linked to unfavorable outcomes among individuals with heart failure (HF). Nevertheless, evidence is scarce regarding the association between fasting blood glucose (FBG) levels and the likelihood of readmission within one year for elderly patients. To address this gap, a retrospective cohort study was conducted, integrating electronic health records of restricted health data from PhysioNet.

Methods The study focused on HF patients aged 60 years and older, utilizing baseline data, comorbidities, and laboratory test results as covariates. A total of 374 patients were included in the study. The relationship between 1-year readmission rates and various glucose levels was assessed using Kaplan-Meier plots. The analysis employed three multivariate Cox regression models to examine patients with varying glucose levels.

Results Following adjustments for relevant factors, an association was observed between FBG levels and the rate of readmission in elderly patients with HF (HR=1.0264 [95% CI 0.9994–1.0541]). The diabetes group faced a higher risk of readmission compared to the normal group. However, this difference in outcome events was not statistically significant, with hazard ratios and their corresponding 95% confidence intervals of 1.2134 (0.9811~1.5007), 1.2393 (0.9993~1.5371), and 1.1905 (0.9570~1.4809), respectively. The robustness of the model was further demonstrated through risk models with subgroup analysis, revealing that FBG levels consistently exerted a stable effect on outcome events, unaffected by covariates such as age, gender, body mass index, glomerular filtration rate, and brain natriuretic peptide.

Conclusion These findings suggest a notable association between elevated FBG at the time of initial hospitalization and the likelihood of readmission within one year among elderly patients with HF.

Publication History

Received: 10 September 2023
Received: 28 November 2023

Accepted: 13 December 2023

Article published online:
24 January 2024

© 2024. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

• References

• 1 Tsao CW, Aday AW, Almarzooq ZI. et al. Heart disease and stroke statistics—2023 update: A report from the American Heart Association. Circulation 2023; 147: e93-e621
  PubMedGoogle Scholar
• 2 Kamalesh M.. Heart failure in diabetes and related conditions. J Card Fail 2007; 13: 861-873
  CrossrefPubMedGoogle Scholar
• 3 Gheorghiade M, Vaduganathan M, Fonarow GC. et al. Rehospitalization for heart failure: Problems and perspectives. J Am Coll Cardiol 2013; 61: 391-403
  CrossrefPubMedGoogle Scholar
• 4 Dungan KM, Osei K, Nagaraja HN. et al. Relationship between glycemic control and readmission rates in patients hospitalized with congestive heart failure during implementation of hospital-wide initiatives. Endocr Pract 2010; 16: 945-951
  CrossrefPubMedGoogle Scholar
• 5 Kistorp C, Galatius S, Gustafsson F. et al. Prevalence and characteristics of diabetic patients in a chronic heart failure population. Int J Cardiol 2005; 100: 281-287
  CrossrefPubMedGoogle Scholar
• 6 Alagiakrishnan K, Banach M, Jones LG. et al. Medication management of chronic heart failure in older adults. Drugs Aging 2013; 30: 765-782
  CrossrefPubMedGoogle Scholar
• 7 Zhang Z, Cao L, Chen R. et al. Electronic healthcare records and external outcome data for hospitalized patients with heart failure. Sci Data 2021; 8: 46
  CrossrefPubMedGoogle Scholar
• 8 Goldberger AL, Amaral LA, Glass L. et al. PhysioBank, PhysioToolkit, and PhysioNet: Components of a new research resource for complex physiologic signals. Circulation 2000; 101: E215-E220
  CrossrefPubMedGoogle Scholar
• 9 Force T, McDonagh TA, Metra M. et al. 2021; ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). With the special contribution of the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail 2022: 24
  PubMedGoogle Scholar
• 10 von Elm E, Altman DG, Egger M. et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: Guidelines for reporting observational studies. Int J Surg 2014; 12: 1495-1499
  CrossrefPubMedGoogle Scholar
• 11 Nunez E, Steyerberg EW, Nunez J. Regression modeling strategies. Rev Esp Cardiol 2011; 64: 501-507
  PubMedGoogle Scholar
• 12 Hansen KN, Noori M, Christiansen EH. et al. Impact of diabetes on long-term all-cause re-hospitalization after revascularization with percutaneous coronary intervention. Diab Vasc Dis Res 2022; 19 14791641221113788
  PubMedGoogle Scholar
• 13 Okura H, Inoue H, Tomon M. et al. Impaired glucose tolerance as a determinant of early deterioration of left ventricular diastolic function in middle-aged healthy subjects. Am J Cardiol 2000; 85: 790-A9
  CrossrefPubMedGoogle Scholar
• 14 Chun KH, Oh J, Lee CJ. et al. In-hospital glycemic variability and all-cause mortality among patients hospitalized for acute heart failure. Cardiovasc Diabetol 2022; 21: 291
  CrossrefPubMedGoogle Scholar
• 15 Benedict CR, Weiner DH, Johnstone DE. et al. Comparative neurohormonal responses in patients with preserved and impaired left ventricular ejection fraction: Results of the Studies of Left Ventricular Dysfunction (SOLVD) Registry. The SOLVD Investigators. J Am Coll Cardiol 1993; 22: 146A-153A
  CrossrefPubMedGoogle Scholar
• 16 Marx N, Federici M, Schütt K. et al. 2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes: Developed by the task force on the management of cardiovascular disease in patients with diabetes of the European Society of Cardiology (ESC). Eur Heart J 2023; 44: 4043-4140
  CrossrefPubMedGoogle Scholar